Since its establishment in 2007, the Michael G. DeGroote Institute for Infectious Disease Research (IIDR) has been active in providing seed funding for new collaborations and high-risk projects focused around the overarching themes of anti-infective innovation, diagnostics, and laboratory and clinical collaboration.
Committed to helping eliminate the global threat of antimicrobial resistance, the newly established David Braley Centre for Antibiotic Discovery (DBCAD) has further demonstrated its commitment to fostering scientific collaboration by providing significant seed funding for milestone-driven projects related to antimicrobial research and discovery.
The purpose of these funding initiatives is to provide opportunities for IIDR & DBCAD members to work collaboratively and creatively. The funding provides support for trainees that are essential for the project and operating funds to help members generate preliminary data and provide evidence for collaboration that will enable them to secure additional funding from other agencies.
Following a review of submitted research proposals, the IIDR and DBCAD are pleased to announce this year’s research funding recipients. Congratulations to this year’s recipients, and special thanks to the late David Braley for making this initiative possible.